Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Telix Pharmaceuticals
Fierce Biotech
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals.
James Waldron
Apr 13, 2026 7:24am
After buyouts, Telix unveils new radiopharma spinoff Rhine
Oct 22, 2024 3:05pm
Telix expansion continues with $250M acquisition of RLS
Sep 23, 2024 10:00am
Telix takes on isotope manufacturer ARTMS for up to $82M
Mar 5, 2024 1:29pm
Telix moves to acquire CDMO IsoTherapeutics in $13.6M deal
Feb 28, 2024 9:26am
Telix buys Lilly's failed cancer drug Lartruvo for $5 million
Apr 11, 2022 11:01am
